Hemostatic and Tissue Sealing Agents Market

Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.
Hemostatic and Tissue Sealing Agents Market contains market size and forecasts of Hemostatic and Tissue Sealing Agents in global, including the following market information:
Global Hemostatic and Tissue Sealing Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hemostatic and Tissue Sealing Agents Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hemostatic and Tissue Sealing Agents companies in 2021 (%)
The global Hemostatic and Tissue Sealing Agents market was valued at 2882.9 million in 2021 and is projected to reach US$ 3514.7 million by 2028, at a CAGR of 2.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hemostatic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hemostatic and Tissue Sealing Agents include J&J, Baxter, C R Bard, B Braun, Integra Life Sciences, Advance Medical Solution, CSL Behring, CryoLife and Zimmer Biomet, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hemostatic and Tissue Sealing Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemostatic and Tissue Sealing Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostatic and Tissue Sealing Agents Market Segment Percentages, by Type, 2021 (%)
Hemostatic
Sealant Gum
Global Hemostatic and Tissue Sealing Agents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostatic and Tissue Sealing Agents Market Segment Percentages, by Application, 2021 (%)
Minimally Invasive Surgery
General Surgery
Other
Global Hemostatic and Tissue Sealing Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostatic and Tissue Sealing Agents Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemostatic and Tissue Sealing Agents revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hemostatic and Tissue Sealing Agents revenues share in global market, 2021 (%)
Key companies Hemostatic and Tissue Sealing Agents sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hemostatic and Tissue Sealing Agents sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
J&J
Baxter
C R Bard
B Braun
Integra Life Sciences
Advance Medical Solution
CSL Behring
CryoLife
Zimmer Biomet
Pfizer
Medtronic
Smith & Nephew
Cohera Medical
Shanghai Haohai Biological Technology Co. Ltd.
Shandong Saikesaisi Biotechnology Co., Ltd
Chang ShaHai Run biological technology Co, LTD